Trigyn Technologies Limited

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TCS.BO has a market cap of 8.9T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TCS.BO trades at ₹2,472.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TCS.BO's P/E ratio is 18.17. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TCS.BO's ROE of +0.46%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TCS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TCS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TCS.NS has a market cap of 8.9T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TCS.NS trades at ₹2,472.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TCS.NS's P/E ratio is 18.17. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TCS.NS's ROE of +0.46%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TCS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TCS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, INFY.BO has a market cap of 5.2T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while INFY.BO trades at ₹1,277.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas INFY.BO's P/E ratio is 18.32. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to INFY.BO's ROE of +0.30%. Regarding short-term risk, TRIGYN.NS is more volatile compared to INFY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check INFY.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, INFY.NS has a market cap of 5.2T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while INFY.NS trades at ₹1,276.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas INFY.NS's P/E ratio is 17.82. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to INFY.NS's ROE of +0.30%. Regarding short-term risk, TRIGYN.NS is more volatile compared to INFY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check INFY.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, HCLTECH.BO has a market cap of 3.9T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while HCLTECH.BO trades at ₹1,429.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas HCLTECH.BO's P/E ratio is 23.58. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to HCLTECH.BO's ROE of +0.23%. Regarding short-term risk, TRIGYN.NS is more volatile compared to HCLTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check HCLTECH.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, HCLTECH.NS has a market cap of 3.9T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while HCLTECH.NS trades at ₹1,429.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas HCLTECH.NS's P/E ratio is 23.56. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to HCLTECH.NS's ROE of +0.23%. Regarding short-term risk, TRIGYN.NS is more volatile compared to HCLTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check HCLTECH.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, WIPRO.BO has a market cap of 2.1T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while WIPRO.BO trades at ₹203.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas WIPRO.BO's P/E ratio is 16.09. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to WIPRO.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to WIPRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check WIPRO.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, WIPRO.NS has a market cap of 2.1T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while WIPRO.NS trades at ₹202.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas WIPRO.NS's P/E ratio is 16.08. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to WIPRO.NS's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to WIPRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check WIPRO.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, LTIM.NS has a market cap of 1.3T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while LTIM.NS trades at ₹4,535.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas LTIM.NS's P/E ratio is 28.28. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to LTIM.NS's ROE of +0.21%. Regarding short-term risk, TRIGYN.NS is more volatile compared to LTIM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check LTIM.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, LTIM.BO has a market cap of 1.3T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while LTIM.BO trades at ₹4,476.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas LTIM.BO's P/E ratio is 27.93. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to LTIM.BO's ROE of +0.21%. Regarding short-term risk, TRIGYN.NS is more volatile compared to LTIM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check LTIM.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, LTM.NS has a market cap of 1.3T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while LTM.NS trades at ₹4,466.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas LTM.NS's P/E ratio is 27.91. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to LTM.NS's ROE of +0.29%. Regarding short-term risk, TRIGYN.NS is more volatile compared to LTM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check LTM.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TECHM.BO has a market cap of 1.3T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TECHM.BO trades at ₹1,435.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TECHM.BO's P/E ratio is 27.53. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TECHM.BO's ROE of +0.17%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TECHM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TECHM.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TECHM.NS has a market cap of 1.3T. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TECHM.NS trades at ₹1,435.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TECHM.NS's P/E ratio is 27.59. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TECHM.NS's ROE of +0.17%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TECHM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TECHM.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, PERSISTENT.NS has a market cap of 840.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while PERSISTENT.NS trades at ₹5,377.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas PERSISTENT.NS's P/E ratio is 48.57. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to PERSISTENT.NS's ROE of +0.25%. Regarding short-term risk, TRIGYN.NS is more volatile compared to PERSISTENT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check PERSISTENT.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, PERSISTENT.BO has a market cap of 840.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while PERSISTENT.BO trades at ₹5,375.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas PERSISTENT.BO's P/E ratio is 48.55. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to PERSISTENT.BO's ROE of +0.25%. Regarding short-term risk, TRIGYN.NS is more volatile compared to PERSISTENT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check PERSISTENT.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MPHASIS.NS has a market cap of 441.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MPHASIS.NS trades at ₹2,316.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MPHASIS.NS's P/E ratio is 24.57. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MPHASIS.NS's ROE of +0.19%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MPHASIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MPHASIS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MPHASIS.BO has a market cap of 441.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MPHASIS.BO trades at ₹2,315.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MPHASIS.BO's P/E ratio is 24.22. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MPHASIS.BO's ROE of +0.19%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MPHASIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MPHASIS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, COFORGE.BO has a market cap of 413.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while COFORGE.BO trades at ₹1,231.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas COFORGE.BO's P/E ratio is 36.85. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to COFORGE.BO's ROE of +0.16%. Regarding short-term risk, TRIGYN.NS is more volatile compared to COFORGE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check COFORGE.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, COFORGE.NS has a market cap of 413.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while COFORGE.NS trades at ₹1,231.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas COFORGE.NS's P/E ratio is 36.84. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to COFORGE.NS's ROE of +0.16%. Regarding short-term risk, TRIGYN.NS is more volatile compared to COFORGE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check COFORGE.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, LTTS.BO has a market cap of 356B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while LTTS.BO trades at ₹3,358.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas LTTS.BO's P/E ratio is 28.30. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to LTTS.BO's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to LTTS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check LTTS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, LTTS.NS has a market cap of 355.7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while LTTS.NS trades at ₹3,356.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas LTTS.NS's P/E ratio is 28.28. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to LTTS.NS's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to LTTS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check LTTS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, HEXT.NS has a market cap of 288.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while HEXT.NS trades at ₹473.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas HEXT.NS's P/E ratio is 21.37. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to HEXT.NS's ROE of +0.24%. Regarding short-term risk, TRIGYN.NS is more volatile compared to HEXT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check HEXT.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TATATECH.BO has a market cap of 227.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TATATECH.BO trades at ₹560.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TATATECH.BO's P/E ratio is 42.77. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TATATECH.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TATATECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TATATECH.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TATATECH.NS has a market cap of 227.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TATATECH.NS trades at ₹560.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TATATECH.NS's P/E ratio is 42.84. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TATATECH.NS's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TATATECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TATATECH.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, KPITTECH.NS has a market cap of 193.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while KPITTECH.NS trades at ₹709.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas KPITTECH.NS's P/E ratio is 27.03. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to KPITTECH.NS's ROE of +0.23%. Regarding short-term risk, TRIGYN.NS is more volatile compared to KPITTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check KPITTECH.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, KPITTECH.BO has a market cap of 193.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while KPITTECH.BO trades at ₹709.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas KPITTECH.BO's P/E ratio is 27.06. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to KPITTECH.BO's ROE of +0.23%. Regarding short-term risk, TRIGYN.NS is more volatile compared to KPITTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check KPITTECH.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, REDINGTON.NS has a market cap of 170.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while REDINGTON.NS trades at ₹218.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas REDINGTON.NS's P/E ratio is 9.68. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to REDINGTON.NS's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to REDINGTON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check REDINGTON.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, REDINGTON.BO has a market cap of 170.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while REDINGTON.BO trades at ₹218.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas REDINGTON.BO's P/E ratio is 9.68. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to REDINGTON.BO's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to REDINGTON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check REDINGTON.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, FSL.NS has a market cap of 149.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while FSL.NS trades at ₹216.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas FSL.NS's P/E ratio is 24.22. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to FSL.NS's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to FSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check FSL.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, FSL.BO has a market cap of 149.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while FSL.BO trades at ₹216.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas FSL.BO's P/E ratio is 24.22. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to FSL.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to FSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check FSL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, HEXAWARE.NS has a market cap of 141.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while HEXAWARE.NS trades at ₹470.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas HEXAWARE.NS's P/E ratio is 22.98. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to HEXAWARE.NS's ROE of +0.25%. Regarding short-term risk, TRIGYN.NS is more volatile compared to HEXAWARE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check HEXAWARE.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ECLERX.BO has a market cap of 136.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ECLERX.BO trades at ₹1,450.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ECLERX.BO's P/E ratio is 20.85. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ECLERX.BO's ROE of +0.29%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ECLERX.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ECLERX.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ECLERX.NS has a market cap of 135.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ECLERX.NS trades at ₹1,450.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ECLERX.NS's P/E ratio is 20.82. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ECLERX.NS's ROE of +0.29%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ECLERX.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ECLERX.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ZENSARTECH.BO has a market cap of 125B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ZENSARTECH.BO trades at ₹549.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ZENSARTECH.BO's P/E ratio is 17.06. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ZENSARTECH.BO's ROE of +0.18%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ZENSARTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ZENSARTECH.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ZENSARTECH.NS has a market cap of 124.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ZENSARTECH.NS trades at ₹549.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ZENSARTECH.NS's P/E ratio is 17.27. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ZENSARTECH.NS's ROE of +0.18%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ZENSARTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ZENSARTECH.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, BSOFT.NS has a market cap of 102B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while BSOFT.NS trades at ₹365.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas BSOFT.NS's P/E ratio is 21.92. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to BSOFT.NS's ROE of +0.13%. Regarding short-term risk, TRIGYN.NS is more volatile compared to BSOFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check BSOFT.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, BSOFT.BO has a market cap of 102B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while BSOFT.BO trades at ₹365.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas BSOFT.BO's P/E ratio is 21.95. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to BSOFT.BO's ROE of +0.13%. Regarding short-term risk, TRIGYN.NS is more volatile compared to BSOFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check BSOFT.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SONATSOFTW.NS has a market cap of 67.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SONATSOFTW.NS trades at ₹242.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SONATSOFTW.NS's P/E ratio is 15.22. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SONATSOFTW.NS's ROE of +0.26%. Regarding short-term risk, TRIGYN.NS is more volatile compared to SONATSOFTW.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check SONATSOFTW.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SONATSOFTW.BO has a market cap of 67.1B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SONATSOFTW.BO trades at ₹242.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SONATSOFTW.BO's P/E ratio is 15.22. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SONATSOFTW.BO's ROE of +0.26%. Regarding short-term risk, TRIGYN.NS is more volatile compared to SONATSOFTW.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check SONATSOFTW.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, RSYSTEMINT.BO has a market cap of 63.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while RSYSTEMINT.BO trades at ₹531.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas RSYSTEMINT.BO's P/E ratio is 106.05. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to RSYSTEMINT.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to RSYSTEMINT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check RSYSTEMINT.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, HAPPSTMNDS.BO has a market cap of 56.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while HAPPSTMNDS.BO trades at ₹373.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas HAPPSTMNDS.BO's P/E ratio is 30.35. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to HAPPSTMNDS.BO's ROE of +0.11%. Regarding short-term risk, TRIGYN.NS is more volatile compared to HAPPSTMNDS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check HAPPSTMNDS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, HAPPSTMNDS.NS has a market cap of 56.1B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while HAPPSTMNDS.NS trades at ₹373.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas HAPPSTMNDS.NS's P/E ratio is 30.41. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to HAPPSTMNDS.NS's ROE of +0.11%. Regarding short-term risk, TRIGYN.NS is more volatile compared to HAPPSTMNDS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check HAPPSTMNDS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MASTEK.NS has a market cap of 48.7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MASTEK.NS trades at ₹1,571.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MASTEK.NS's P/E ratio is 12.92. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MASTEK.NS's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MASTEK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MASTEK.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MASTEK.BO has a market cap of 48.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MASTEK.BO trades at ₹1,567.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MASTEK.BO's P/E ratio is 12.88. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MASTEK.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MASTEK.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MASTEK.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, DATAMATICS.BO has a market cap of 41.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while DATAMATICS.BO trades at ₹697.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas DATAMATICS.BO's P/E ratio is 21.17. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to DATAMATICS.BO's ROE of +0.14%. Regarding short-term risk, TRIGYN.NS is more volatile compared to DATAMATICS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check DATAMATICS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, DATAMATICS.NS has a market cap of 41.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while DATAMATICS.NS trades at ₹696.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas DATAMATICS.NS's P/E ratio is 21.13. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to DATAMATICS.NS's ROE of +0.14%. Regarding short-term risk, TRIGYN.NS is more volatile compared to DATAMATICS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check DATAMATICS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, CAMS.NS has a market cap of 34.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while CAMS.NS trades at ₹705.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas CAMS.NS's P/E ratio is 37.76. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to CAMS.NS's ROE of +0.41%. Regarding short-term risk, TRIGYN.NS is more volatile compared to CAMS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check CAMS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, CAMS.BO has a market cap of 34.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while CAMS.BO trades at ₹704.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas CAMS.BO's P/E ratio is 37.72. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to CAMS.BO's ROE of +0.41%. Regarding short-term risk, TRIGYN.NS is more volatile compared to CAMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check CAMS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ASMTEC.BO has a market cap of 33.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ASMTEC.BO trades at ₹2,827.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ASMTEC.BO's P/E ratio is 69.96. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ASMTEC.BO's ROE of +0.31%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ASMTEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ASMTEC.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, CIGNITITEC.BO has a market cap of 33.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while CIGNITITEC.BO trades at ₹1,213.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas CIGNITITEC.BO's P/E ratio is 11.10. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to CIGNITITEC.BO's ROE of +0.31%. Regarding short-term risk, TRIGYN.NS is more volatile compared to CIGNITITEC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check CIGNITITEC.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, CIGNITITEC.NS has a market cap of 33.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while CIGNITITEC.NS trades at ₹1,211.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas CIGNITITEC.NS's P/E ratio is 11.05. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to CIGNITITEC.NS's ROE of +0.31%. Regarding short-term risk, TRIGYN.NS is more volatile compared to CIGNITITEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check CIGNITITEC.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, RPSGVENT.NS has a market cap of 32.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while RPSGVENT.NS trades at ₹976.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas RPSGVENT.NS's P/E ratio is -34.48. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to RPSGVENT.NS's ROE of -0.03%. Regarding short-term risk, TRIGYN.NS is less volatile compared to RPSGVENT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check RPSGVENT.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, RPSGVENT.BO has a market cap of 32.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while RPSGVENT.BO trades at ₹975.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas RPSGVENT.BO's P/E ratio is -34.53. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to RPSGVENT.BO's ROE of -0.03%. Regarding short-term risk, TRIGYN.NS is less volatile compared to RPSGVENT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check RPSGVENT.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, RSYSTEMS.NS has a market cap of 30.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while RSYSTEMS.NS trades at ₹258.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas RSYSTEMS.NS's P/E ratio is 17.20. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to RSYSTEMS.NS's ROE of +0.24%. Regarding short-term risk, TRIGYN.NS is more volatile compared to RSYSTEMS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check RSYSTEMS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, RSYSTEMS.BO has a market cap of 30.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while RSYSTEMS.BO trades at ₹258.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas RSYSTEMS.BO's P/E ratio is 17.32. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to RSYSTEMS.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to RSYSTEMS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check RSYSTEMS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, PROTEAN.NS has a market cap of 21.7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while PROTEAN.NS trades at ₹533.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas PROTEAN.NS's P/E ratio is 24.00. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to PROTEAN.NS's ROE of +0.09%. Regarding short-term risk, TRIGYN.NS is more volatile compared to PROTEAN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check PROTEAN.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, PROTEAN.BO has a market cap of 21.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while PROTEAN.BO trades at ₹532.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas PROTEAN.BO's P/E ratio is 23.94. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to PROTEAN.BO's ROE of +0.09%. Regarding short-term risk, TRIGYN.NS is more volatile compared to PROTEAN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check PROTEAN.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SASKEN.BO has a market cap of 18.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SASKEN.BO trades at ₹1,236.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SASKEN.BO's P/E ratio is 49.46. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SASKEN.BO's ROE of +0.05%. Regarding short-term risk, TRIGYN.NS is less volatile compared to SASKEN.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check SASKEN.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SASKEN.NS has a market cap of 18.7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SASKEN.NS trades at ₹1,229.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SASKEN.NS's P/E ratio is 49.35. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SASKEN.NS's ROE of +0.05%. Regarding short-term risk, TRIGYN.NS is more volatile compared to SASKEN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check SASKEN.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SAKSOFT.BO has a market cap of 17.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SAKSOFT.BO trades at ₹135.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SAKSOFT.BO's P/E ratio is 14.31. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SAKSOFT.BO's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to SAKSOFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check SAKSOFT.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SAKSOFT.NS has a market cap of 17.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SAKSOFT.NS trades at ₹134.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SAKSOFT.NS's P/E ratio is 14.28. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SAKSOFT.NS's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to SAKSOFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check SAKSOFT.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ACCELYA.BO has a market cap of 16.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ACCELYA.BO trades at ₹1,128.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ACCELYA.BO's P/E ratio is 15.64. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ACCELYA.BO's ROE of +0.39%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ACCELYA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ACCELYA.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ACCELYA.NS has a market cap of 16.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ACCELYA.NS trades at ₹1,127.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ACCELYA.NS's P/E ratio is 15.63. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ACCELYA.NS's ROE of +0.39%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ACCELYA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ACCELYA.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MCLOUD.NS has a market cap of 15.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MCLOUD.NS trades at ₹25.88.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MCLOUD.NS's P/E ratio is 14.22. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MCLOUD.NS's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is less volatile compared to MCLOUD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check MCLOUD.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MCLOUD.BO has a market cap of 15.2B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MCLOUD.BO trades at ₹25.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MCLOUD.BO's P/E ratio is 14.21. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MCLOUD.BO's ROE of +0.21%. Regarding short-term risk, TRIGYN.NS is less volatile compared to MCLOUD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check MCLOUD.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, DSSL.NS has a market cap of 13.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while DSSL.NS trades at ₹1,065.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas DSSL.NS's P/E ratio is 16.44. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to DSSL.NS's ROE of +0.36%. Regarding short-term risk, TRIGYN.NS is more volatile compared to DSSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check DSSL.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, BGDL.BO has a market cap of 13.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while BGDL.BO trades at ₹133.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas BGDL.BO's P/E ratio is 431.55. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to BGDL.BO's ROE of +0.07%. Regarding short-term risk, TRIGYN.NS is more volatile compared to BGDL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check BGDL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, DSSL.BO has a market cap of 13.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while DSSL.BO trades at ₹1,062.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas DSSL.BO's P/E ratio is 16.08. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to DSSL.BO's ROE of +0.36%. Regarding short-term risk, TRIGYN.NS is more volatile compared to DSSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check DSSL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, AURUM.NS has a market cap of 12.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while AURUM.NS trades at ₹169.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas AURUM.NS's P/E ratio is -50.16. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to AURUM.NS's ROE of -0.07%. Regarding short-term risk, TRIGYN.NS is more volatile compared to AURUM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check AURUM.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, AURUM.BO has a market cap of 12.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while AURUM.BO trades at ₹168.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas AURUM.BO's P/E ratio is -50.83. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to AURUM.BO's ROE of -0.07%. Regarding short-term risk, TRIGYN.NS is more volatile compared to AURUM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check AURUM.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ORIENTTECH.NS has a market cap of 12.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ORIENTTECH.NS trades at ₹273.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ORIENTTECH.NS's P/E ratio is 58.55. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ORIENTTECH.NS's ROE of +0.07%. Regarding short-term risk, TRIGYN.NS is less volatile compared to ORIENTTECH.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check ORIENTTECH.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, EXPLEOSOL.NS has a market cap of 11.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while EXPLEOSOL.NS trades at ₹747.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas EXPLEOSOL.NS's P/E ratio is 10.90. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to EXPLEOSOL.NS's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to EXPLEOSOL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check EXPLEOSOL.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, EXPLEOSOL.BO has a market cap of 11.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while EXPLEOSOL.BO trades at ₹745.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas EXPLEOSOL.BO's P/E ratio is 10.87. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to EXPLEOSOL.BO's ROE of +0.15%. Regarding short-term risk, TRIGYN.NS is more volatile compared to EXPLEOSOL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check EXPLEOSOL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MMWL.BO has a market cap of 11.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MMWL.BO trades at ₹10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MMWL.BO's P/E ratio is 251.25. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MMWL.BO's ROE of +0.03%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MMWL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MMWL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, 3IINFOTECH.BO has a market cap of 9.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while 3IINFOTECH.BO trades at ₹54.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas 3IINFOTECH.BO's P/E ratio is 111.67. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to 3IINFOTECH.BO's ROE of +0.00%. Regarding short-term risk, TRIGYN.NS is more volatile compared to 3IINFOTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check 3IINFOTECH.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, NINSYS.BO has a market cap of 7.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while NINSYS.BO trades at ₹409.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas NINSYS.BO's P/E ratio is 24.82. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to NINSYS.BO's ROE of +0.49%. Regarding short-term risk, TRIGYN.NS is less volatile compared to NINSYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check NINSYS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, NINSYS.NS has a market cap of 7.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while NINSYS.NS trades at ₹402.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas NINSYS.NS's P/E ratio is 24.46. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to NINSYS.NS's ROE of +0.44%. Regarding short-term risk, TRIGYN.NS is less volatile compared to NINSYS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check NINSYS.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, VAKRANGEE.NS has a market cap of 7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while VAKRANGEE.NS trades at ₹6.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas VAKRANGEE.NS's P/E ratio is 58.55. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to VAKRANGEE.NS's ROE of +0.06%. Regarding short-term risk, TRIGYN.NS is less volatile compared to VAKRANGEE.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check VAKRANGEE.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, VAKRANGEE.BO has a market cap of 7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while VAKRANGEE.BO trades at ₹6.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas VAKRANGEE.BO's P/E ratio is 58.45. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to VAKRANGEE.BO's ROE of +0.06%. Regarding short-term risk, TRIGYN.NS is more volatile compared to VAKRANGEE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check VAKRANGEE.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, XCHANGING.NS has a market cap of 6.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while XCHANGING.NS trades at ₹62.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas XCHANGING.NS's P/E ratio is 12.04. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to XCHANGING.NS's ROE of +0.16%. Regarding short-term risk, TRIGYN.NS is more volatile compared to XCHANGING.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check XCHANGING.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, XCHANGING.BO has a market cap of 6.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while XCHANGING.BO trades at ₹62.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas XCHANGING.BO's P/E ratio is 11.94. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to XCHANGING.BO's ROE of +0.16%. Regarding short-term risk, TRIGYN.NS is more volatile compared to XCHANGING.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check XCHANGING.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ADSL.BO has a market cap of 6.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ADSL.BO trades at ₹113.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ADSL.BO's P/E ratio is 19.93. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ADSL.BO's ROE of +0.06%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ADSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ADSL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ADSL.NS has a market cap of 6.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ADSL.NS trades at ₹112.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ADSL.NS's P/E ratio is 19.77. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ADSL.NS's ROE of +0.06%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ADSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ADSL.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MINDTECK.NS has a market cap of 5.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MINDTECK.NS trades at ₹181.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MINDTECK.NS's P/E ratio is 20.65. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MINDTECK.NS's ROE of +0.11%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MINDTECK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MINDTECK.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, MINDTECK.BO has a market cap of 5.8B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while MINDTECK.BO trades at ₹181.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas MINDTECK.BO's P/E ratio is 20.58. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to MINDTECK.BO's ROE of +0.11%. Regarding short-term risk, TRIGYN.NS is more volatile compared to MINDTECK.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check MINDTECK.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ONWARDTEC.BO has a market cap of 5.7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ONWARDTEC.BO trades at ₹252.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ONWARDTEC.BO's P/E ratio is 12.72. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ONWARDTEC.BO's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is less volatile compared to ONWARDTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check ONWARDTEC.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, ONWARDTEC.NS has a market cap of 5.7B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while ONWARDTEC.NS trades at ₹251.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas ONWARDTEC.NS's P/E ratio is 12.67. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to ONWARDTEC.NS's ROE of +0.20%. Regarding short-term risk, TRIGYN.NS is more volatile compared to ONWARDTEC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check ONWARDTEC.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SIGMA.NS has a market cap of 4.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SIGMA.NS trades at ₹45.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SIGMA.NS's P/E ratio is 18.27. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SIGMA.NS's ROE of +0.51%. Regarding short-term risk, TRIGYN.NS is less volatile compared to SIGMA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check SIGMA.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, SIGMA.BO has a market cap of 4.6B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while SIGMA.BO trades at ₹44.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas SIGMA.BO's P/E ratio is 17.37. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to SIGMA.BO's ROE of +0.51%. Regarding short-term risk, TRIGYN.NS is less volatile compared to SIGMA.BO. This indicates potentially lower risk in terms of short-term price fluctuations for TRIGYN.NS.Check SIGMA.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TERASOFT.NS has a market cap of 4.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TERASOFT.NS trades at ₹358.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TERASOFT.NS's P/E ratio is 21.51. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TERASOFT.NS's ROE of +0.17%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TERASOFT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TERASOFT.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, TERASOFT.BO has a market cap of 4.5B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while TERASOFT.BO trades at ₹357.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas TERASOFT.BO's P/E ratio is 21.46. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to TERASOFT.BO's ROE of +0.17%. Regarding short-term risk, TRIGYN.NS is more volatile compared to TERASOFT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check TERASOFT.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, DIGISPICE.NS has a market cap of 4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while DIGISPICE.NS trades at ₹17.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas DIGISPICE.NS's P/E ratio is 63.93. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to DIGISPICE.NS's ROE of +0.00%. Regarding short-term risk, TRIGYN.NS is more volatile compared to DIGISPICE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check DIGISPICE.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, DIGISPICE.BO has a market cap of 4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while DIGISPICE.BO trades at ₹17.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas DIGISPICE.BO's P/E ratio is 63.63. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to DIGISPICE.BO's ROE of +0.00%. Regarding short-term risk, TRIGYN.NS is more volatile compared to DIGISPICE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check DIGISPICE.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, CYBERTECH.BO has a market cap of 3.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while CYBERTECH.BO trades at ₹125.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas CYBERTECH.BO's P/E ratio is 11.90. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to CYBERTECH.BO's ROE of +0.14%. Regarding short-term risk, TRIGYN.NS is more volatile compared to CYBERTECH.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check CYBERTECH.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, XTGLOBAL.BO has a market cap of 3.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while XTGLOBAL.BO trades at ₹29.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas XTGLOBAL.BO's P/E ratio is 44.18. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to XTGLOBAL.BO's ROE of +0.06%. Regarding short-term risk, TRIGYN.NS is more volatile compared to XTGLOBAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check XTGLOBAL.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, CYBERTECH.NS has a market cap of 3.9B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while CYBERTECH.NS trades at ₹123.76.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas CYBERTECH.NS's P/E ratio is 11.72. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to CYBERTECH.NS's ROE of +0.14%. Regarding short-term risk, TRIGYN.NS is more volatile compared to CYBERTECH.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check CYBERTECH.NS's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, INSPIRISYS.BO has a market cap of 3.4B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while INSPIRISYS.BO trades at ₹85.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas INSPIRISYS.BO's P/E ratio is 9.03. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to INSPIRISYS.BO's ROE of +0.82%. Regarding short-term risk, TRIGYN.NS is more volatile compared to INSPIRISYS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check INSPIRISYS.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, 3IINFOLTD.BO has a market cap of 3.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while 3IINFOLTD.BO trades at ₹16.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas 3IINFOLTD.BO's P/E ratio is 5.36. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to 3IINFOLTD.BO's ROE of +0.76%. Regarding short-term risk, TRIGYN.NS is more volatile compared to 3IINFOLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check 3IINFOLTD.BO's competition here

TRIGYN.NS plays a significant role within the Technology sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, TRIGYN.NS stands at 1.7B. In comparison, INSPIRISYS.NS has a market cap of 3.3B. Regarding current trading prices, TRIGYN.NS is priced at ₹54.34, while INSPIRISYS.NS trades at ₹84.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

TRIGYN.NS currently has a P/E ratio of 57.81, whereas INSPIRISYS.NS's P/E ratio is 8.90. In terms of profitability, TRIGYN.NS's ROE is +0.01%, compared to INSPIRISYS.NS's ROE of +0.82%. Regarding short-term risk, TRIGYN.NS is more volatile compared to INSPIRISYS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for TRIGYN.NS.Check INSPIRISYS.NS's competition here